ABSTRACT
HEMOPHILUS B VACCINE Trade names: ActHIB (Sanofi-Aventis), Comvax (Merck), HibTITER (Lederle), OmniHIB (GSK), PedivaxHIB (Merck), ProHIBIT (Connaught) Indications: Hemophilus B immunization Class: Vaccine Half-life: N/A Clinically important, potentially hazardous interactions with: azathioprine, basiliximab, corticosteroids, cyclosporine, daclizumab, glatiramer, mycophenolate, sirolimus, tacrolimus Pregnancy category: C
Skin Anaphylactoid reactions/Anaphylaxis Angioedema Erythema [2] Erythema multiforme Facial edema Hypersensitivity Pigmentation Pruritus Rash Urticaria
Central Nervous System Fever [1] Guillain-Barre´ syndrome [1] Seizures
Neuromuscular/Skeletal Asthenia (fatigue)
Local Injection-site edema [1] Injection-site induration Injection-site pain [1]
HEPARIN Trade names: Hep-Flush (Wyeth), Viaflex (Baxter) Indications: Venous thrombosis, pulmonary embolism, intravascular coagulation, peripheral arterial embolism Class: Anticoagulant, Heparinoid Half-life: 1.5 hours Clinically important, potentially hazardous interactions with: acenocoumarol, aliskiren, antihistamines, aspirin, balsalazide, bivalirudin, butabarbital, ceftobiprole, dabigatran, danaparoid, desvenlafaxine, iloprost, nandrolone, nicotine, nitroglycerin, palifermin, piperacillin / tazobactam, salicylates, tirofiban, warfarin Pregnancy category: C Note: A higher incidence of bleeding has been reported in patients over 60 years of age, especially women. Contraindicated in patients with severe thrombocyopenia.
